Envoy Medical, Inc. (COCH)
NASDAQ: COCH · IEX Real-Time Price · USD
6.07
+1.02 (20.20%)
At close: Apr 15, 2024, 4:00 PM
5.76
-0.31 (-5.07%)
After-hours: Apr 15, 2024, 6:57 PM EDT
Company Description
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum.
Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants.
The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023.
Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Envoy Medical, Inc.
| Country | United States |
| Founded | 1995 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 34 |
| CEO | Brent T. Lucas Esq. |
Contact Details
Address: 4875 White Bear Parkway White Bear Lake, Minnesota 55110 United States | |
| Phone | 651-361-8000 |
| Website | envoymedical.com |
Stock Details
| Ticker Symbol | COCH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001840877 |
| ISIN Number | US29415V1098 |
| Employer ID | 86-1369123 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Brent T. Lucas Esq. | Chief Executive Officer and Director |
| David R. Wells | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 12, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Apr 5, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 1, 2024 | 10-K | Annual Report |
| Mar 4, 2024 | 8-K | Current Report |
| Feb 15, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 18, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jan 17, 2024 | 10-Q/A | [Amend] Quarterly report |
| Dec 19, 2023 | 8-K | Current Report |
| Nov 17, 2023 | 10-Q | Quarterly Report |